Keyphrases
Schizophrenia
100%
Clozapine
75%
Antipsychotics
59%
Schizophrenic Patients
59%
Atypical Antipsychotics
50%
Major Depressive Disorder
26%
Patients with Schizophrenia
25%
Phencyclidine
24%
Tardive Dyskinesia
21%
Dopamine
20%
Antipsychotic-induced Weight Gain
18%
Haloperidol
18%
5-hydroxytryptamine
18%
Olanzapine
18%
Depressed Patients
18%
Prolactin Secretion
18%
Nucleus Accumbens
17%
Dopamine Release
17%
Typical Antipsychotics
15%
Serotonin
15%
Medial Prefrontal Cortex (mPFC)
15%
Polymorphism
15%
Treatment-resistant Schizophrenia
15%
Risperidone
14%
Prolactin
14%
Serotonin 2A Receptor (5-HT2AR)
14%
Psychosis
14%
Negative Symptoms
14%
Schizophrenia Symptoms
13%
Schizoaffective Disorder
13%
Blood Platelets
13%
Psychopathology
13%
Plasma Prolactin
13%
5-HT1A
13%
Platelets
12%
Association Study
12%
Suicide
12%
Schizophrenia Treatment
11%
Novel Object Recognition
11%
Creatine Phosphokinase
11%
Weight Gain
10%
Serum Prolactin Level
10%
Cognitive Impairment
10%
Affective Disorders
10%
Imipramine
10%
Chlorpromazine
10%
Psychotic Patients
10%
5-HT1A Receptor
10%
Lurasidone
10%
Clozapine Treatment
10%
Neuroscience
Antipsychotic
79%
Clozapine
73%
Atypical Antipsychotic
39%
Typical Antipsychotic
35%
Blood Plasma
34%
Prolactin
33%
Serotonin
30%
Receptor
28%
Major Depressive Disorder
26%
Phencyclidine
20%
Prefrontal Cortex
20%
Platelet
20%
Tardive Dyskinesia
18%
Olanzapine
17%
Cognitive Disorders
16%
Haloperidol
16%
Nucleus Accumbens
16%
Cortisol
16%
Dopamine Release
16%
Creatine Kinase
15%
Agonist
15%
Negative Syndrome
14%
Serotonergic
14%
Risperidone
13%
In Vivo
12%
Schizoaffective Disorder
12%
Receptor Gene
12%
Striatum
12%
Mood Disorder
11%
Positive Syndrome
11%
Treatment-Resistant Schizophrenia
11%
Lurasidone
10%
Placebo
10%
Cognitive Function
10%
5-HT1A Receptor
9%
Behavior (Neuroscience)
8%
Antidepressant
8%
Bipolar Disorder
8%
Hippocampus
8%
Amphetamine
8%
Meta-Analysis
8%
Receptor Agonists
8%
Chlorpromazine
8%
Acetylcholine
7%
Single-Nucleotide Polymorphism
7%
Receptor Antagonist
7%
5-HT2A Receptor
7%
Dopaminergic
7%
Skeletal Muscle
7%
Imipramine
7%
Pharmacology, Toxicology and Pharmaceutical Science
Clozapine
50%
Antipsychotic
41%
Prolactin
35%
Atypical Antipsychotics
35%
Receptor
35%
Typical Antipsychotic
24%
Serotonin
21%
Phencyclidine
19%
Cognitive Defect
14%
Creatine Kinase
13%
Olanzapine
13%
Risperidone
11%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
11%
Negative Syndrome
10%
Tardive Dyskinesia
10%
Effusion
10%
Side Effect
10%
Hydrocortisone
10%
Dopamine Receptor Stimulating Agent
10%
Antipsychotic Drug
9%
Placebo
9%
Acetylcholine
9%
Positive Syndrome
8%
Treatment-Resistant Schizophrenia
8%
Schizoaffective Psychosis
8%
Lurasidone
8%
Chlorpromazine
7%
Extrapyramidal Symptoms
7%
Partial Agonist
7%
Diseases
6%
Dopamine Receptor
5%
Buspirone
5%
Pharmacotherapy
5%
Mood Disorder
5%
Antidepressant
5%
Receptor Agonist
5%
8-OH-DPAT
5%
Receptor Antagonist
5%
Amine Oxidase (Flavin Containing)
5%
5 Hydroxytryptophan
5%